Ocular Therapeutix, Inc., a publicly traded biopharmaceutical company that develops specialized treatments for eye diseases and conditions, disclosed in a security filing that it renewed the lease for its manufacturing space at 36 Crosby Drive in Bedford, Massachusetts, where the firm occupies approximately 20,445 square feet.